Clinical Trial

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

Study acronym: IAB-2
Recruiting
View on ClinicalTrials.gov →
Summary
A study taking place at multiple sites in the United States, Europe and Brazil to evaluate how well a new therapy for severe COPD/emphysema works, and how safe it is.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-09
Trial Details
NCT Number NCT07119229
Lead Sponsor Pulmair Medical, Inc.
Conditions Emphysema or COPD, Emphysema, COPD
Enrollment 60 participants
Start Date 2026-03-25
Primary Completion 2027-07 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-06-03